Cargando…

Immunological characterization and diagnostic models of RNA N6-methyladenosine regulators in Alzheimer's disease

Alzheimer's disease (AD) is the most prevalent form of dementia, and it displays both clinical and molecular variability. RNA N6-methyladenosine (m6A) regulators are involved in a wide range of essential cellular processes. In this study, we aimed to identify molecular signatures associated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, Yuan, Ma, Qi, Zhou, Xue-Rui, Wang, Huan, Dong, Jian-Hua, Gao, Li-Na, Zhang, Tian, Li, Yan-Yi, Gong, Ting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477294/ https://www.ncbi.nlm.nih.gov/pubmed/37666846 http://dx.doi.org/10.1038/s41598-023-41129-x

Ejemplares similares

RNA N6-Methyladenosine Modifications and Its Roles in Alzheimer’s Disease
por: Zhang, Runjiao, et al.
Publicado: (2022)

The emerging roles of N(6)-methyladenosine in osteoarthritis
por: Liu, Hui, et al.
Publicado: (2022)

Inducible and reversible RNA N(6)-methyladenosine editing
por: Shi, Huaxia, et al.
Publicado: (2022)

N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
por: Huang, Wei, et al.
Publicado: (2021)

Functional Implications of Active N(6)-Methyladenosine in Plants
por: Zheng, Hongxiang, et al.
Publicado: (2020)

Role of N6-methyladenosine Modification in Cardiac Remodeling
por: Choy, ManTing, et al.
Publicado: (2022)

Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia
por: Zheng, Xue, et al.
Publicado: (2021)

N(6)-Methyladenosine and Viral Infection
por: Dang, Wei, et al.
Publicado: (2019)

N(6)-Methyladenosine Methylomic Landscape of Ureteral Deficiency in Reflux Uropathy and Obstructive Uropathy
por: Shi, Hua, et al.
Publicado: (2022)

Evolutionary Implications of the RNA N(6)-Methyladenosine Methylome in Plants
por: Miao, Zhenyan, et al.
Publicado: (2021)

Characterization of N(6)-methyladenosine in cattle-yak testis tissue
por: Wang, Xingdong, et al.
Publicado: (2022)

Identification and characterization of N6‐methyladenosine modification of circRNAs in glioblastoma
por: Zhang, Yuhao, et al.
Publicado: (2021)

Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease
por: Qiu, Zhiqiang, et al.
Publicado: (2023)

N6-methyladenosine dynamics in neurodevelopment and aging, and its potential role in Alzheimer’s disease
por: Shafik, Andrew M., et al.
Publicado: (2021)

Upregulated N6-Methyladenosine RNA in Peripheral Blood: Potential Diagnostic Biomarker for Breast Cancer
por: Xiao, Han, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) methylation in ischemia–reperfusion injury
por: Yao, Weifeng, et al.
Publicado: (2020)

Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer’s disease
por: Ni, Pengyun, et al.
Publicado: (2023)

Regulation of N6-Methyladenosine in the Differentiation of Cancer Stem Cells and Their Fate
por: Xu, Ya, et al.
Publicado: (2020)

Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker
por: Zhao, Chengwen, et al.
Publicado: (2021)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Molecular Characterization and Clinical Relevance of N(6)-Methyladenosine Regulators in Metastatic Prostate Cancer
por: Liu, Qiwei, et al.
Publicado: (2022)

mRNA N(6)-methyladenosine methylation of postnatal liver development in pig
por: He, Shen, et al.
Publicado: (2017)

N6-methyladenosine regulator-mediated methylation modification patterns and immune infiltration characterization in Polycystic Ovary Syndrome (PCOS)
por: Zhou, Sihan, et al.
Publicado: (2023)

The essential role of N6-methyladenosine RNA methylation in complex eye diseases
por: Li, Xiaohua, et al.
Publicado: (2022)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

RNA N(6)-methyladenosine modification in cancers: current status and perspectives
por: Deng, Xiaolan, et al.
Publicado: (2018)

N(6)-Methyladenosine: A Novel RNA Imprint in Human Cancer
por: Yu, Sihui, et al.
Publicado: (2019)

N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target
por: Quan, Chao, et al.
Publicado: (2021)

N6-methyladenosine-modified circRIMS2 mediates synaptic and memory impairments by activating GluN2B ubiquitination in Alzheimer's disease
por: Wang, Xiong, et al.
Publicado: (2023)

Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer
por: Liu, Jinhui, et al.
Publicado: (2021)

N6-methyladenosine regulates ATM expression and downstream signaling
por: Zhang, Xiaoyue, et al.
Publicado: (2021)

Functions of N6-methyladenosine and its role in cancer
por: He, Liuer, et al.
Publicado: (2019)

Pan-Cancer Prognostic, Immunity, Stemness, and Anticancer Drug Sensitivity Characterization of N6-Methyladenosine RNA Modification Regulators in Human Cancers
por: Li, Rui, et al.
Publicado: (2021)

N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
por: Liu, Chi, et al.
Publicado: (2022)

Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
por: Zhang, YanJun, et al.
Publicado: (2023)

Landscape of N(6)-Methyladenosine Modification Patterns in Human Ameloblastoma
por: Niu, Xing, et al.
Publicado: (2020)

The Roles of N(6)-Methyladenosine in Human Diseases
por: An, Shanshan, et al.
Publicado: (2019)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_abe8q02if4ic9ft6b3a70ttuo5